Gene therapy approaches for wiskott-aldrich syndrome

Project Information

LOICDUPRE

Grant agreement ID: QLK2-CT-1999-51231

Project closed

Start date 1 April 2000

End date 31 March 2002

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 130 712,00

EU contribution € 130 712,00

Coordinated by

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO
Italy

Objective

We will develop gene therapy approaches for wiskott-Aldrich syndrome, based on ex vivo transduction of T lymphocytes or hematopoietic progenitors with retroviral vectors. Efficacy and safety will be assessed in preclinical studies.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

• medical and health sciences › medical biotechnology › genetic engineering › gene therapy

You need to log in or register to use this function

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO

• EU contribution: No data
• Address: Via Olgettina 58 ; 20132 MILANO ; Italy
• Total cost: No data